Universal avian flu vaccine (aiv)
AssigneeDEI Biopharma
InventorMatthias Magoola
Life of this patent
Estimating the term…
Abstract
The universal vaccine of the present invention can induce one or more targeted immune responses against a broad range of AIV subtypes by incorporating their antigen-producing sequences for cross-protection against various subtypes of AIV. In another embodiment, the invention is manufactured by recombinant or RNA technology, either for in vitro manufacturing or vivo administration, and administered by parenteral or inhalation route.
Claims16
A universal avian influenza vaccine formulation designed to confer cross-protection against multiple AIV subtypes, comprising a plurality of conserved peptide epitopes derived from the hemagglutinin and neuraminidase proteins encoded by H1N1, H1N2, and H3N2 subtypes.
Dependencies are inferred from the claim text.